Opgen, Inc.’s $5.4 Million Stock Offering


Sichenzia Ross Ference represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.

Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease.

The Sichenzia Ross Ference LLP team was led by partners Tom Rose (Picture), Gregory Sichenzia and Jay Yamamoto.

Involved fees earner: Thomas Rose – Sichenzia Ross Ference LLP; Gregory Sichenzia – Sichenzia Ross Ference LLP; Jay Yamamoto – Sichenzia Ross Ference LLP;

Law Firms: Sichenzia Ross Ference LLP;

Clients: Aegis Capital Corporation;